Global Biopharmaceutical Company - Bristol Myers Squibb
WEBBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Bristol Myers Squibb - Wikipedia
WEBThe Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Products and medicines - Bristol Myers Squibb
WEBBristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.
About us - Bristol Myers Squibb
WEBWe promote health equity and seek to improve the health outcomes of populations disproportionately affected by serious diseases. Learn about global biopharmaceutical innovator Bristol Myers Squibb, helping millions to fight cancer, cardiovascular disease, HIV/AIDS, and more.
Your Meaningful Career at Bristol Myers Squibb
WEBDiscover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.
Bristol Myers Squibb - LinkedIn
WEBBristol Myers Squibb | 1,464,840 followers on LinkedIn. At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most...
Bristol Myers Squibb - Bristol Myers Squibb to Acquire Turning …
WEBJun 3, 2022 — Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company. Acquisition Brings Repotrectinib, a Potential Best-in-Class, Next-Generation ROS1/NTRK Inhibitor with Differentiated Duration of Response for Patients with ROS1-positive First-Line Non-Small Cell Lung Cancer; Expected to …
Bristol Myers Squibb - Bristol Myers Squibb Completes …
WEBMar 18, 2024 — PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”). With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers ...
Bristol-Myers Squibb Company (BMY) - Yahoo Finance
WEBBristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology,...
Our company: Industry leadership in BioPharma - Bristol Myers Squibb
WEBBristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.